The first half of the year was characterized by dramatic swings in the markets, both in terms of price movements and ...

Cigna stock trades at a 15% discount, offering an entry point despite mixed Q2 results. Read here for an investment analysis ...

Pfizer beats Q2 estimates with $14.7B revenue and $0.78 EPS. Management showed extreme confidence by raising full-year EPS ...

Read here for insights on Waterdrop (WDP) stock's revenue growth, innovative insurance products, and company outlook amid ...

Blue Owl Capital saw continued double-digit growth in net investment income. See why OBDC is a top pick for income investors.

Managers see the largest mega-cap growth stocks as crowded trades, with many holding less exposure due to high valuations and ...

BioSig Technologies pivots to blockchain with a focus on tokenized Gold after past struggles in medtech and a merger with ...

Microvast thrives with strong revenue growth in EV and energy storage markets. Attractive valuation and growth potential ease ...

The idea behind the InfraCap REIT Preferred ETF is simple: gain exposure to real estate-linked cash flows, but with a higher ...

Oscar Health has a lot of opportunities with the growth of Health Reimbursement Arrangements. See why OSCR stock is a buy ...

LegalZoom surpasses 2Q25 expectations with subscription growth and upmarket expansion. Challenges in ARPU and retention limit ...

The frothy performance of the stock market in recent weeks may have created the impression that all that worry earlier in the ...